JP5513775B2 - Bath salt and scale control method - Google Patents
Bath salt and scale control method Download PDFInfo
- Publication number
- JP5513775B2 JP5513775B2 JP2009127911A JP2009127911A JP5513775B2 JP 5513775 B2 JP5513775 B2 JP 5513775B2 JP 2009127911 A JP2009127911 A JP 2009127911A JP 2009127911 A JP2009127911 A JP 2009127911A JP 5513775 B2 JP5513775 B2 JP 5513775B2
- Authority
- JP
- Japan
- Prior art keywords
- mass
- bath
- carbonate
- sodium
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims description 15
- 235000019341 magnesium sulphate Nutrition 0.000 title description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 58
- 238000003287 bathing Methods 0.000 claims description 42
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 41
- 239000001488 sodium phosphate Substances 0.000 claims description 37
- 229910000406 trisodium phosphate Inorganic materials 0.000 claims description 35
- 235000019801 trisodium phosphate Nutrition 0.000 claims description 35
- 239000003795 chemical substances by application Substances 0.000 claims description 30
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 26
- 239000013040 bath agent Substances 0.000 claims description 24
- 230000001747 exhibiting effect Effects 0.000 claims description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 42
- 239000000203 mixture Substances 0.000 description 25
- 239000003205 fragrance Substances 0.000 description 23
- 229910000029 sodium carbonate Inorganic materials 0.000 description 21
- 235000017550 sodium carbonate Nutrition 0.000 description 21
- 238000009472 formulation Methods 0.000 description 20
- 230000000694 effects Effects 0.000 description 15
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 13
- -1 etc. Substances 0.000 description 13
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 12
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 229910052938 sodium sulfate Inorganic materials 0.000 description 8
- 235000011152 sodium sulphate Nutrition 0.000 description 8
- 235000017557 sodium bicarbonate Nutrition 0.000 description 7
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 7
- 229910000019 calcium carbonate Inorganic materials 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 208000025599 Heat Stress disease Diseases 0.000 description 5
- 235000002639 sodium chloride Nutrition 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 230000001629 suppression Effects 0.000 description 5
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 4
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 4
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 239000008399 tap water Substances 0.000 description 4
- 235000020679 tap water Nutrition 0.000 description 4
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000723346 Cinnamomum camphora Species 0.000 description 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
- 229960000846 camphor Drugs 0.000 description 3
- 229930008380 camphor Natural products 0.000 description 3
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229940041616 menthol Drugs 0.000 description 3
- 239000010445 mica Substances 0.000 description 3
- 229910052618 mica group Inorganic materials 0.000 description 3
- 238000001000 micrograph Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 239000003352 sequestering agent Substances 0.000 description 3
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 3
- 235000019345 sodium thiosulphate Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 240000008067 Cucumis sativus Species 0.000 description 2
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- 235000009421 Myristica fragrans Nutrition 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 235000011203 Origanum Nutrition 0.000 description 2
- 240000000783 Origanum majorana Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- CQPFMGBJSMSXLP-UHFFFAOYSA-M acid orange 7 Chemical compound [Na+].OC1=CC=C2C=CC=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 CQPFMGBJSMSXLP-UHFFFAOYSA-M 0.000 description 2
- 239000001099 ammonium carbonate Substances 0.000 description 2
- 239000003788 bath preparation Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- FGRVOLIFQGXPCT-UHFFFAOYSA-L dipotassium;dioxido-oxo-sulfanylidene-$l^{6}-sulfane Chemical compound [K+].[K+].[O-]S([O-])(=O)=S FGRVOLIFQGXPCT-UHFFFAOYSA-L 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 2
- 239000001095 magnesium carbonate Substances 0.000 description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 2
- 235000014380 magnesium carbonate Nutrition 0.000 description 2
- 229960001047 methyl salicylate Drugs 0.000 description 2
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 2
- 235000019799 monosodium phosphate Nutrition 0.000 description 2
- ZWRUINPWMLAQRD-UHFFFAOYSA-N nonan-1-ol Chemical compound CCCCCCCCCO ZWRUINPWMLAQRD-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- DPLVEEXVKBWGHE-UHFFFAOYSA-N potassium sulfide Chemical compound [S-2].[K+].[K+] DPLVEEXVKBWGHE-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 235000011008 sodium phosphates Nutrition 0.000 description 2
- 235000019830 sodium polyphosphate Nutrition 0.000 description 2
- 229910052979 sodium sulfide Inorganic materials 0.000 description 2
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 239000009538 yokuinin Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- UENOQWSWMYJKIW-UHFFFAOYSA-N 1,2,2-trimethylcyclohexan-1-ol Chemical compound CC1(C)CCCCC1(C)O UENOQWSWMYJKIW-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- UBVSIAHUTXHQTD-UHFFFAOYSA-N 2-n-(4-bromophenyl)-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(NC=2C=CC(Br)=CC=2)=N1 UBVSIAHUTXHQTD-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- MUDSDYNRBDKLGK-UHFFFAOYSA-N 4-methylquinoline Chemical compound C1=CC=C2C(C)=CC=NC2=C1 MUDSDYNRBDKLGK-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- VNFYMAPAENTMMO-UHFFFAOYSA-N 5-chloro-2-methylquinoline Chemical compound ClC1=CC=CC2=NC(C)=CC=C21 VNFYMAPAENTMMO-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 240000006054 Agastache cana Species 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- WLDHEUZGFKACJH-ZRUFZDNISA-K Amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1\N=N\C1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-ZRUFZDNISA-K 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- 235000003826 Artemisia Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 235000005241 Cistus ladanifer Nutrition 0.000 description 1
- 240000008772 Cistus ladanifer Species 0.000 description 1
- 241000911175 Citharexylum caudatum Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 244000166675 Cymbopogon nardus Species 0.000 description 1
- 235000018791 Cymbopogon nardus Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 240000006541 Dactyloctenium aegyptium Species 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000257465 Echinoidea Species 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000402754 Erythranthe moschata Species 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- MBMLMWLHJBBADN-UHFFFAOYSA-N Ferrous sulfide Chemical compound [Fe]=S MBMLMWLHJBBADN-UHFFFAOYSA-N 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 235000010650 Hyssopus officinalis Nutrition 0.000 description 1
- 241000692870 Inachis io Species 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 239000004869 Labdanum Substances 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 244000179970 Monarda didyma Species 0.000 description 1
- 235000010672 Monarda didyma Nutrition 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 244000270834 Myristica fragrans Species 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 229930182559 Natural dye Natural products 0.000 description 1
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 description 1
- 235000010676 Ocimum basilicum Nutrition 0.000 description 1
- 240000007926 Ocimum gratissimum Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- VKCLPVFDVVKEKU-UHFFFAOYSA-N S=[P] Chemical compound S=[P] VKCLPVFDVVKEKU-UHFFFAOYSA-N 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 235000002911 Salvia sclarea Nutrition 0.000 description 1
- 244000182022 Salvia sclarea Species 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 244000125380 Terminalia tomentosa Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 235000013832 Valeriana officinalis Nutrition 0.000 description 1
- 244000126014 Valeriana officinalis Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000005083 Zinc sulfide Substances 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- DRHYDSJKKDNMCR-UHFFFAOYSA-N [S-][S-].[Ca+2] Chemical compound [S-][S-].[Ca+2] DRHYDSJKKDNMCR-UHFFFAOYSA-N 0.000 description 1
- XAQHXGSHRMHVMU-UHFFFAOYSA-N [S].[S] Chemical compound [S].[S] XAQHXGSHRMHVMU-UHFFFAOYSA-N 0.000 description 1
- IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940008075 allyl sulfide Drugs 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 108010027597 alpha-chymotrypsin Proteins 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- UYJXRRSPUVSSMN-UHFFFAOYSA-P ammonium sulfide Chemical compound [NH4+].[NH4+].[S-2] UYJXRRSPUVSSMN-UHFFFAOYSA-P 0.000 description 1
- 229960003116 amyl nitrite Drugs 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 244000030166 artemisia Species 0.000 description 1
- 235000009052 artemisia Nutrition 0.000 description 1
- CJDPJFRMHVXWPT-UHFFFAOYSA-N barium sulfide Chemical compound [S-2].[Ba+2] CJDPJFRMHVXWPT-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- JGIATAMCQXIDNZ-UHFFFAOYSA-N calcium sulfide Chemical compound [Ca]=S JGIATAMCQXIDNZ-UHFFFAOYSA-N 0.000 description 1
- FAYYUXPSKDFLEC-UHFFFAOYSA-L calcium;dioxido-oxo-sulfanylidene-$l^{6}-sulfane Chemical compound [Ca+2].[O-]S([O-])(=O)=S FAYYUXPSKDFLEC-UHFFFAOYSA-L 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229930003633 citronellal Natural products 0.000 description 1
- 235000000983 citronellal Nutrition 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- 229940013361 cresol Drugs 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- RZKNJSIGVZOHKZ-UHFFFAOYSA-N diazanium carbonic acid carbonate Chemical compound [NH4+].[NH4+].OC(O)=O.OC(O)=O.[O-]C([O-])=O RZKNJSIGVZOHKZ-UHFFFAOYSA-N 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
- FSBVERYRVPGNGG-UHFFFAOYSA-N dimagnesium dioxido-bis[[oxido(oxo)silyl]oxy]silane hydrate Chemical compound O.[Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O FSBVERYRVPGNGG-UHFFFAOYSA-N 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 235000019524 disodium tartrate Nutrition 0.000 description 1
- FPAYXBWMYIMERV-UHFFFAOYSA-L disodium;5-methyl-2-[[4-(4-methyl-2-sulfonatoanilino)-9,10-dioxoanthracen-1-yl]amino]benzenesulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1S([O-])(=O)=O FPAYXBWMYIMERV-UHFFFAOYSA-L 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229940009662 edetate Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229940074774 glycyrrhizinate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229960001867 guaiacol Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- WPFVBOQKRVRMJB-UHFFFAOYSA-N hydroxycitronellal Chemical compound O=CCC(C)CCCC(C)(C)O WPFVBOQKRVRMJB-UHFFFAOYSA-N 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- 229940076263 indole Drugs 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- FPNCFEPWJLGURZ-UHFFFAOYSA-L iron(2+);sulfite Chemical compound [Fe+2].[O-]S([O-])=O FPNCFEPWJLGURZ-UHFFFAOYSA-L 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 239000000177 juniperus communis l. berry Substances 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- SXQCTESRRZBPHJ-UHFFFAOYSA-M lissamine rhodamine Chemical compound [Na+].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S([O-])(=O)=O)C=C1S([O-])(=O)=O SXQCTESRRZBPHJ-UHFFFAOYSA-M 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000001115 mace Substances 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- CXHHBNMLPJOKQD-UHFFFAOYSA-M methyl carbonate Chemical compound COC([O-])=O CXHHBNMLPJOKQD-UHFFFAOYSA-M 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- CSDTZUBPSYWZDX-UHFFFAOYSA-N n-pentyl nitrite Chemical compound CCCCCON=O CSDTZUBPSYWZDX-UHFFFAOYSA-N 0.000 description 1
- 239000000978 natural dye Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 239000001702 nutmeg Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940049953 phenylacetate Drugs 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
- 229940067107 phenylethyl alcohol Drugs 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- KXXXUIKPSVVSAW-UHFFFAOYSA-K pyranine Chemical compound [Na+].[Na+].[Na+].C1=C2C(O)=CC(S([O-])(=O)=O)=C(C=C3)C2=C2C3=C(S([O-])(=O)=O)C=C(S([O-])(=O)=O)C2=C1 KXXXUIKPSVVSAW-UHFFFAOYSA-K 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 238000007788 roughening Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 150000003377 silicon compounds Chemical class 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940037001 sodium edetate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229910000031 sodium sesquicarbonate Inorganic materials 0.000 description 1
- 235000018341 sodium sesquicarbonate Nutrition 0.000 description 1
- 239000001433 sodium tartrate Substances 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- YPMOSINXXHVZIL-UHFFFAOYSA-N sulfanylideneantimony Chemical compound [Sb]=S YPMOSINXXHVZIL-UHFFFAOYSA-N 0.000 description 1
- 150000004763 sulfides Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 235000001508 sulfur Nutrition 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- AFNRRBXCCXDRPS-UHFFFAOYSA-N tin(ii) sulfide Chemical compound [Sn]=S AFNRRBXCCXDRPS-UHFFFAOYSA-N 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- WCTAGTRAWPDFQO-UHFFFAOYSA-K trisodium;hydrogen carbonate;carbonate Chemical compound [Na+].[Na+].[Na+].OC([O-])=O.[O-]C([O-])=O WCTAGTRAWPDFQO-UHFFFAOYSA-K 0.000 description 1
- 235000016788 valerian Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960003487 xylose Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229910052984 zinc sulfide Inorganic materials 0.000 description 1
- DRDVZXDWVBGGMH-UHFFFAOYSA-N zinc;sulfide Chemical compound [S-2].[Zn+2] DRDVZXDWVBGGMH-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本発明は、保温や疲労回復などの入浴効果を与えることに加え、浴槽のざらつき等の原因となるスケールの発生を抑制することができる入浴剤と、浴湯に発生するスケールの抑制方法とに関する。 The present invention relates to a bathing agent capable of suppressing the generation of scale that causes roughness of a bathtub and the like, and a method for suppressing the scale generated in bath water, in addition to providing bathing effects such as heat retention and fatigue recovery. .
従来から、保温や疲労回復などの入浴効果を高める目的で、炭酸ナトリウム、硫酸ナトリウム、炭酸水素ナトリウム等の無機塩類を主成分とし、これに油分、香料等を適宜配合した入浴剤が広く用いられている。このような入浴剤に含有させる成分として、炭酸ナトリウム等の炭酸塩は、十分な入浴効果が期待される炭酸ガス発生型入浴剤や、いわゆる温泉特有の作用効果を呈するアルカリ性入浴剤には欠かせない成分であり、多くの入浴剤に配合されている。 Conventionally, for the purpose of enhancing the bathing effect such as heat retention and fatigue recovery, bathing agents mainly containing inorganic salts such as sodium carbonate, sodium sulfate, sodium hydrogen carbonate, etc., and oils, perfumes, etc. are appropriately used. ing. As a component to be contained in such a bath agent, carbonates such as sodium carbonate are indispensable for a carbon dioxide-generating bath agent that is expected to have a sufficient bath effect or an alkaline bath agent that exhibits a so-called action characteristic of a hot spring. It is not a component and is blended in many bath salts.
しかしながら、炭酸ナトリウム等の炭酸塩を主成分とする入浴剤を使用すると、水道水中のカルシウムイオンと入浴剤中の炭酸イオンとが炭酸カルシウムを形成してスケールを発生させる、という問題があった。このようなスケールは、浴槽に付着してざらつきの原因となり、さらに浴槽のみならず風呂釜や加熱装置内部にも付着、堆積して、装置の不具合等をまねく原因となることもある。 However, when a bathing agent containing a carbonate such as sodium carbonate as a main component is used, there is a problem that calcium ions in tap water and carbonate ions in the bathing agent form calcium carbonate to generate scale. Such a scale adheres to the bathtub and causes roughness. Further, the scale adheres to and accumulates not only in the bathtub but also in the bath tub and the heating apparatus, and may cause malfunction of the apparatus.
そこで、炭酸ナトリウムを主成分とする入浴剤を用いた際のスケールの発生を抑制する技術として、当該入浴剤に、エデト酸二ナトリウム(EDTA)、クエン酸ナトリウム、ポリリン酸ナトリウムといった金属イオン封鎖剤を配合することが提案されている(特許文献1)。 Therefore, as a technique for suppressing the generation of scale when using a bathing agent mainly composed of sodium carbonate, the bathing agent includes sequestering agents such as disodium edetate (EDTA), sodium citrate, and sodium polyphosphate. Has been proposed (Patent Document 1).
しかしながら、上述した従来のスケール抑制技術で用いられている金属イオン封鎖剤を配合した入浴剤では、スケールの発生を抑制する効果が十分ではなく、使用後の浴槽のざらつきを防止するまでには至らず、さらなる改良が望まれていた。 However, the bathing agent blended with the sequestering agent used in the above-described conventional scale suppression technology is not sufficient in suppressing the generation of scale, and does not reach the roughness of the bathtub after use. However, further improvements were desired.
そこで、本発明は、保温や疲労回復などの入浴効果を与える炭酸塩含有のアルカリ性入浴剤であり、炭酸カルシウムからなるスケールの発生を抑制して浴槽のざらつきを防止しうる入浴剤と、浴湯に発生するスケールの抑制方法とを提供することを目的とする。 Therefore, the present invention is a carbonate-containing alkaline bathing agent that provides a bathing effect such as heat retention and fatigue recovery, a bathing agent that can prevent the occurrence of roughness of the bathtub by suppressing the occurrence of scales composed of calcium carbonate, and bath water It is an object of the present invention to provide a method for suppressing the scale generated in the above.
本発明者らは、上記課題を解決すべく鋭意研究を重ねた結果、リン酸三ナトリウムが、炭酸塩含有のアルカリ性入浴剤を使用した時のスケールの発生を抑制する効果に優れることを見出し、本発明を完成した。 As a result of intensive studies to solve the above problems, the present inventors have found that trisodium phosphate is excellent in the effect of suppressing the generation of scale when using a carbonate-containing alkaline bath, The present invention has been completed.
すなわち、本発明は以下の構成からなる。
(1)炭酸塩を必須成分とし、浴湯に溶解させた時にアルカリ性を示す入浴剤であって、スケールの発生を抑制するためにリン酸三ナトリウムが配合されてなることを特徴とする入浴剤。
(2)リン酸三ナトリウムの配合量が、入浴剤全量に対して、1〜10質量%である、前記(1)記載の入浴剤。
(3)浴湯に溶解させた時のpHが9〜11である、前記(1)または(2)に記載の入浴剤。
(4)炭酸塩を溶解させたアルカリ性を示す浴湯に発生するスケールを抑制する方法であって、リン酸三ナトリウムを添加することを特徴とするスケール抑制方法。
That is, the present invention has the following configuration.
(1) A bathing agent which contains carbonate as an essential component and exhibits alkalinity when dissolved in bath water, and contains trisodium phosphate in order to suppress generation of scale. .
(2) The bath agent according to (1), wherein the amount of trisodium phosphate is 1 to 10% by mass based on the total amount of the bath agent.
(3) The bath agent according to (1) or (2), wherein the pH when dissolved in bath water is 9 to 11.
(4) A method for suppressing a scale generated in an alkaline bath water in which carbonate is dissolved, wherein the sodium salt is added with trisodium phosphate.
本発明によれば、保温や疲労回復などの入浴効果を与える炭酸塩含有のアルカリ性入浴剤であり、炭酸カルシウムからなるスケールの発生を抑制して浴槽のざらつきを防止しうる入浴剤を提供するとともに、炭酸塩を溶解させたアルカリ性を示す浴湯に発生するスケールの抑制方法を提供することができる。 According to the present invention, there is provided a carbonate-containing alkaline bathing agent that provides a bathing effect such as heat retention and fatigue recovery, and can provide a bathing agent that can prevent the occurrence of the roughness of the bathtub by suppressing the generation of scale composed of calcium carbonate. In addition, it is possible to provide a method for suppressing scale generated in bath water exhibiting alkalinity in which carbonate is dissolved.
本発明の入浴剤は、炭酸塩を必須成分とするものである。炭酸塩としては、例えば、炭酸ナトリウム、セスキ炭酸ナトリウム、炭酸カリウム、炭酸マグネシウム、炭酸アンモニウム、セスキ炭酸アンモニウム等が挙げられる。これらの炭酸塩は、1種又は2種以上を組み合わせて用いることができる。これらの中でも、保温や疲労回復などの入浴効果、天然泉に似たまろやかな湯ざわり、湯上りのつるつる感、すべすべ感といった感触を十分に楽しむことができることから、炭酸ナトリウムが好ましい。
上記炭酸塩の配合量は、入浴剤全量に対して、40〜95質量%、好ましくは40〜50質量%とするのがよい。
The bath agent of the present invention contains carbonate as an essential component. Examples of the carbonate include sodium carbonate, sodium sesquicarbonate, potassium carbonate, magnesium carbonate, ammonium carbonate, and ammonium sesquicarbonate. These carbonates can be used alone or in combination of two or more. Among these, sodium carbonate is preferable because it can sufficiently enjoy a bathing effect such as heat retention and fatigue recovery, a mellow hot water resembling a natural spring, a smooth feeling after bathing, and a smooth feeling.
The blending amount of the carbonate is 40 to 95% by mass, preferably 40 to 50% by mass, based on the total amount of the bath agent.
本発明の入浴剤は、スケールの発生を抑制するためにリン酸三ナトリウムが配合されてなる。入浴剤に配合する成分としては、浴湯に投入した時に速やかに溶解しうる溶解性や、浴湯のpHを所期の範囲に調整しうることが求められるが、リン酸三ナトリウムは、これらの適性を備えるとともに、アルカリ性の浴湯中でのスケールの抑制に高い効果を発揮する。このリン酸三ナトリウムのスケール抑制効果は、とりわけ炭酸ナトリウムによりアルカリ性を呈する浴湯において顕著に発揮される。 The bath agent of the present invention is formulated with trisodium phosphate to suppress the generation of scale. Ingredients to be added to the bathing agent, it is required to be able to dissolve quickly when it is added to the bath water and to adjust the pH of the bath water to a desired range. It is highly effective in suppressing scale in alkaline bath water. This scale-inhibiting effect of trisodium phosphate is particularly prominent in bath water that is alkaline due to sodium carbonate.
上記リン酸三ナトリウムの配合量は、入浴剤全量に対して、1〜10質量%であることが好ましく、より好ましくは1〜5質量%とするのがよい。リン酸三ナトリウムの配合量が1質量%未満であると、スケールの抑制効果が不十分となるおそれがあり、一方、10質量%を超えると、上述したような入浴効果、湯ざわり、感触が損なわれるおそれがある。 The blending amount of the trisodium phosphate is preferably 1 to 10% by mass, more preferably 1 to 5% by mass, based on the total amount of the bath agent. When the blending amount of trisodium phosphate is less than 1% by mass, the effect of suppressing the scale may be insufficient. On the other hand, when it exceeds 10% by mass, the bathing effect, the feeling of hot water, and the touch as described above may occur. There is a risk of damage.
本発明の入浴剤には、上述した炭酸塩およびリン酸三ナトリウムの他に、必要に応じて、当該分野で知られている各種成分(以下「任意成分」と称することもある)を1種又は2種以上組合せて配合することができる。以下に本発明の入浴剤に配合することのできる任意成分を例示するが、ここに記載された成分等に限定されないことは言うまでもない。 In the bath agent of the present invention, in addition to the above-mentioned carbonate and trisodium phosphate, one kind of various components known in the art (hereinafter also referred to as “optional component”) is used, if necessary. Or it can mix | blend in combination of 2 or more types. Although the arbitrary component which can be mix | blended with the bath agent of this invention is illustrated below, it cannot be overemphasized that it is not limited to the component etc. which were described here.
○ 無機塩類
塩化ナトリウム、塩化カリウム、塩化アンモニウム等の塩化物、炭酸水素ナトリウム、炭酸水素カリウム、炭酸水素アンモニウム等の重炭酸塩、硫酸ナトリウム、硫酸アルミニウム、硫酸鉄、チオ硫酸ナトリウム、チオ硫酸カリウム、次亜硫酸ナトリウム等の硫酸塩、硝酸ナトリウム、硝酸カリウム、硝酸カルシウム等の硝酸塩、リン酸ナトリウム(リン酸三ナトリウムを除く)、ポリリン酸ナトリウム、リン酸水素カルシウム等のリン酸塩、イオウ、硫化ナトリウム、硫化カリウム、亜硫化鉄等の硫化物、無水ケイ酸、メタケイ酸、雲母末、中性白土等のケイ素化合物、水酸化ナトリウム、水酸化カルシウム等の水酸化物、ホウ砂、ホウ酸、酸化カルシウム、臭化カリウム、過マンガン酸カリウム、人工カルス塩、鉱泉、鉱砂、湯の花等。
○ 有機酸類
リンゴ酸、クエン酸、コハク酸、フマル酸、酒石酸、ピロリドンカルボン酸等。
○ 油性成分類
ヌカ油、オリーブ油、大豆油、流動パラフィン、白色ワセリン、ステアリルアルコール、ミリスチン酸、ラウリン酸、パルミチン酸、モノグリセライド、トリグリセライド、米ぬかエキス、米胚芽油、セラミド、シリコーン等。
○ Inorganic salts Chlorides such as sodium chloride, potassium chloride, ammonium chloride, bicarbonates such as sodium bicarbonate, potassium bicarbonate, ammonium bicarbonate, sodium sulfate, aluminum sulfate, iron sulfate, sodium thiosulfate, potassium thiosulfate, Sulfates such as sodium hyposulfite, nitrates such as sodium nitrate, potassium nitrate, and calcium nitrate, phosphates such as sodium phosphate (excluding trisodium phosphate), sodium polyphosphate, calcium hydrogen phosphate, sulfur, sodium sulfide, Sulfides such as potassium sulfide and iron sulfite, silicic anhydride, metasilicic acid, mica powder, silicon compounds such as neutral clay, hydroxides such as sodium hydroxide and calcium hydroxide, borax, boric acid and calcium oxide , Potassium bromide, potassium permanganate, artificial callus salt, spa, mineral sand Yunohana like.
○ Organic acids Malic acid, citric acid, succinic acid, fumaric acid, tartaric acid, pyrrolidone carboxylic acid, etc.
○ Oily components Nuka oil, olive oil, soybean oil, liquid paraffin, white petrolatum, stearyl alcohol, myristic acid, lauric acid, palmitic acid, monoglyceride, triglyceride, rice bran extract, rice germ oil, ceramide, silicone, etc.
○ 高分子物質類
カルボキシメチルセルロース、スチレン重合体エマルション、デキストリン、カゼイン、卵黄末、脱脂粉乳、いりぬか等。
○ 薬効成分類
メントール、カンフル、サリチル酸メチル、サリチル酸、サリチル酸ナトリウム、安息香酸等。
○ 酵素類
トリプシン、α−キモトリプシン、プロメライン、パパイン、プロテアーゼ、プロクターゼ、セラチオペプチダーゼ、リゾチーム、プロメライン、フイシン等。
○ High molecular weight substances Carboxymethylcellulose, styrene polymer emulsion, dextrin, casein, egg yolk powder, skim milk powder, and rice bran.
○ Medicinal components Menthol, camphor, methyl salicylate, salicylic acid, sodium salicylate, benzoic acid, etc.
○ Enzymes Trypsin, α-chymotrypsin, promelain, papain, protease, proctase, cerathiopeptidase, lysozyme, promelain, huisin, etc.
○ 香料・精油類
ハッカ、ユーカリ、レモン、ペルペナ、シトロネラ、カヤプテ、サルピア、タイム、クロープ、ローズマリー、ヒソップ、ジャスミン、カモミル、ネロリ、ヨモギ、ペリラ、マジョラム、ローレル、ジュニパーベリー、ナッツメグ、ジンジャー、オニオン、ガーリック、ラベンダー、ベルガモット、マジョラム、クラリーセージ、ペパーミント、ベージル、ローズ、プチグレン、シナモン、メース、シトラール、シトロネラール、ボルネオール、リナロール、ゲラニオール、ネロール、ロジノール、オレンジ、アルテミジア、カンファー、サルビア、メントール、シネオール、オイゲノール、ヒドロキシシトロネラール、サンダルウッド、コスタス、ラブダナム、アンバー、ムスク、α−ピネン、リモネン、サリチル酸メチル、ソウジュツ、ビャクジュツ、カノコソウ、ケイガイ、コウボク、センキュウ、トウヒ、トウキ、ショウキョク、シャクヤク、オウバク、オウゴン、サンシン、ケイヒ、ニンジン、ブクリョウ、ドクガク、ショウブ、ガイヨウ、マツブサ、ビャクシ、ジュウヤク、ウイキョウ、チンピ、カンピ、カミツレ等の精油類、亜硝酸アミル、トリメチルシクロヘキサノール、アリルサルファイド、ノニルアルコール、デシルアルコール、フェニルエチルアルコール、炭酸メチル、炭酸エチル、フェニル酢酸エステル、グアヤコール、インドール、クレゾール、チオフェノール、p−ジクロロベンゼン、p−メチルキノリン、イソキノリン、ピリジン、アブシンス油酢酸、酢酸エステル、等。
○ Fragrances and essential oils peppermint, eucalyptus, lemon, perpena, citronella, kayapte, salpia, thyme, crope, rosemary, hyssop, jasmine, camomil, neroli, mugwort, perilla, marjoram, laurel, juniper berry, nutmeg, ginger, onion , Garlic, lavender, bergamot, marjoram, clary sage, peppermint, basil, rose, petitgren, cinnamon, mace, citral, citronellal, borneol, linalool, geraniol, nerol, rosinol, orange, artemisia, camphor, salvia, menthol, cineole, eugenol , Hydroxycitronellal, sandalwood, costas, labdanum, amber, musk, α-pinene, limonene, methyl salicylate , Soujutsu, Peacock, valerian, Snapper, Cinnamon, Cucumber, Cucumber, Spruce, Tokyo, Pepper, Peonies, Pokemon, Ogon, Sanshin, Keihi, Carrot, Bud Crest, Dokugaku, Shobu, Guiyou, Pepper, Pepper, Pug Essential oils such as campi and chamomile, amyl nitrite, trimethylcyclohexanol, allyl sulfide, nonyl alcohol, decyl alcohol, phenylethyl alcohol, methyl carbonate, ethyl carbonate, phenylacetate, guaiacol, indole, cresol, thiophenol, p- Dichlorobenzene, p-methylquinoline, isoquinoline, pyridine, absins oil acetic acid, acetate ester, and the like.
○ 顔料類
酸化チタン、タルク、ベンガラ、黄酸化鉄、ケイ酸マグネシウム、マイカ、雲母、チタン、炭酸カルシウム、炭酸マグネシウム、二酸化チタン、無水ケイ酸、酸化亜鉛、これらの被覆粒(顆粒)等。
○ 美白成分類
ビタミンEフェニル酸エステル、ビタミンCおよびその誘導体、エラグ酸、コウジ酸、α−ヒドロキシ酸、ヒアルロン酸等。
○ 色素類
青色1号、青色202号、赤色106号、赤色2号、黄色5号、黄色4号、黄色202号の(1)、緑色3号、橙色205号、黄色202(1)号、緑色204号、緑色201号、赤色102号、青色2号、橙色205号、赤色3号等の法定色素、クロロフィル、リボフラビン、アンナット、アントシアニン等の天然色素等。
○ Pigments Titanium oxide, talc, bengara, yellow iron oxide, magnesium silicate, mica, mica, titanium, calcium carbonate, magnesium carbonate, titanium dioxide, anhydrous silicic acid, zinc oxide, coated particles (granules), etc.
○ Whitening ingredients Vitamin E phenyl ester, vitamin C and its derivatives, ellagic acid, kojic acid, α-hydroxy acid, hyaluronic acid and the like.
○ Pigments Blue No. 1, Blue No. 202, Red No. 106, Red No. 2, Yellow No. 5, Yellow No. 4, Yellow No. 202 (1), Green No. 3, Orange No. 205, Yellow No. 202 (1), Legal dyes such as green No. 204, green No. 201, red No. 102, blue No. 2, orange No. 205, red No. 3, etc., natural dyes such as chlorophyll, riboflavin, annat, anthocyanin, etc.
○ イオウ類
イオウ、チオ硫酸ナトリウム、チオ硫酸カルシウム、チオ硫酸カリウム、硫化カルシウム、重硫化カルシウム、硫化カリウム、硫化ナトリウム、硫化アンモニウム、硫化バリウム、硫化亜鉛、硫化すず、硫化アンチモン、硫化鉄、二硫化炭素、硫化リン等。
○ 皮脂分泌促進成分類
分岐脂肪酸コレステリルエステル、γ−オリザノール、ヨクイニンもしくはヨクイニン抽出物等。
○ ビタミン類
ビタミンA、ビタミンB、ビタミンC、ビタミンD、ビタミンE、ビタミンF、ビタミンH、パントテン酸、ニコチン酸又はその誘導体、ビタミンEニコチン酸エステル、イノシット等。
Sulfur Sulfur, sodium thiosulfate, calcium thiosulfate, potassium thiosulfate, calcium sulfide, calcium disulfide, potassium sulfide, sodium sulfide, ammonium sulfide, barium sulfide, zinc sulfide, tin sulfide, antimony sulfide, iron sulfide, disulfide Carbon, phosphorus sulfide, etc.
○ Sebum secretion-promoting components Branched fatty acid cholesteryl ester, γ-oryzanol, yokuinin or yokuinin extract.
○ Vitamins Vitamin A, Vitamin B, Vitamin C, Vitamin D, Vitamin E, Vitamin F, Vitamin H, Pantothenic acid, nicotinic acid or its derivatives, Vitamin E nicotinic acid ester, inosit and the like.
○ 海藻抽出物類
アナアササ、ミル、ウスバアオノリ、ヒトニグサ、スジアオノリ、カサノリ、ヘライワツダ、ハネモ、ナガミル等の緑藻植物、ウミウチワ、アミジグサ、モズク、イロロ、マツモ、イワヒゲ、ハバノリ、ウルシグサ、カジメ、マコンブ、ワカメ、トロロコンブ、ヒジキ、アラメ、ホンダワラ、ウミトラノオ、スギモリ、オオバモリ等の褐藻植物、アルバアマノリ、アサクサノリ、スサビノリ、ウミゾウメン、ヒラクサ、マクサ、トリアシ、ハナフノリ、フクロフノリ、トリアシ、ヒカデノリ、トサカノリ、トゲキリンサイ、アカバギンナンソウ、コトジツノマタ、ツノマタ、アヤニシキ、マクリ、エゴノリ、オゴノリ、イバラノリ等の紅藻植物等から得られる抽出物等。
○ 冷感物質類
メントール、カンファー、チモール等のメントール誘導体、単環式化合物、二環式アルコール、三環式アルコール、三環式アミド等。
○ Seaweed extracts Anaasasa, Mill, Usubaaonori, Hitonigusa, Sugioonori, Casanori, Heraiwatsuda, Hanemo, Nagarami, etc., Green Algae, Sea Urchin, Amygusa, Mozuku, Iroro, Matsumo, Siwahige, Habanori, Urushigusakon, Babika Trollocombs, hijiki, arame, hondawala, umitranoo, sugimori, batori, etc. Extracts obtained from red algae plants such as Kotojitsunomata, Tsunomata, Ayanishiki, Makri, Egonori, Ogonori, Ibaranori and the like.
○ Cooling sensates Menthol derivatives such as menthol, camphor, thymol, monocyclic compounds, bicyclic alcohols, tricyclic alcohols, tricyclic amides, etc.
○ 保湿成分類
乳酸ナトリウム、酒石酸二ナトリウム、ピロリドンカルボン酸ナトリウム、グルタミン酸二ナトリウム等の有機酸塩類、イソプレングリコール、プロピレングリコール、1,3−ブチレングリコール、グリセリン、キシロース、キシリトール、ソルビトール等の多価アルコール類、ポリエチレングリコール、ポリビニルアルコール、アルギン酸ナトリウム、ポリビニルピロリドン等の水溶性高分子、コンドロイチン硫酸、ヒアルロン酸等のムコ多糖類、コラーゲンやその誘導体、蛋白質、ケラチン、ヒブロイン及びその加水分解物等。
○ Moisturizing ingredients Organic acid salts such as sodium lactate, disodium tartrate, sodium pyrrolidonecarboxylate, disodium glutamate, polyhydric alcohols such as isoprene glycol, propylene glycol, 1,3-butylene glycol, glycerin, xylose, xylitol, sorbitol Water soluble polymers such as polyethylene glycol, polyvinyl alcohol, sodium alginate and polyvinylpyrrolidone, mucopolysaccharides such as chondroitin sulfate and hyaluronic acid, collagen and derivatives thereof, protein, keratin, hybroin and hydrolysates thereof.
○ 界面活性剤
ジオレイン酸ポリエチレングリコール、ポリオキシエチレンソルビタンモノオレエート、ポリオキシエチレンソルビタントリオレエート等。
○ その他
ブドウ糖、ショ糖、トレハロース、フィトコラージュ、イソフラボン、グリチルリチン酸塩およびその誘導体、グリチルレチン酸塩およびその誘導体、パラオキシ安息香酸エステル、イソプロピルメチルフェノール、野菜又は果物抽出物(エキス)、精製水、イオン水、海洋深層水等。
○ Surfactant Polyethylene glycol dioleate, polyoxyethylene sorbitan monooleate, polyoxyethylene sorbitan trioleate, etc.
○ Other Glucose, sucrose, trehalose, phytocollage, isoflavones, glycyrrhizinate and its derivatives, glycyrrhetinate and its derivatives, paraoxybenzoate, isopropylmethylphenol, vegetable or fruit extract (extract), purified water, ions Water, deep ocean water, etc.
上述した任意成分の配合量は、本発明の効果を損なわない範囲で適宜設定すればよい。 What is necessary is just to set the compounding quantity of the arbitrary component mentioned above suitably in the range which does not impair the effect of this invention.
本発明の入浴剤は、浴湯に溶解させた時にアルカリ性を示す入浴剤である。具体的には、本発明の入浴剤を浴湯に溶解させた時のpHは9〜11であることが好ましい。このpHが9未満であると、保温や疲労回復などの入浴効果が不十分となったり、湯ざわり、つるつる感やすべすべ感といった感触を楽しむことができなくなるおそれがあり、一方、pHが11を超えると、皮膚に対する刺激が強くなり、肌が敏感な人などに対しては好ましくない。
本発明の入浴剤は、1gの入浴剤をイオン交換水1000gに20℃で溶解させる溶解性試験において20分以内に完全に溶解することが好ましい。これにより、本発明の入浴剤を浴湯に投入した時に速やかに溶解させることができる。
なお、本発明の入浴剤の剤型は、特に制限されるものではなく、例えば、粉末剤、顆粒剤、微細粒剤、錠剤、ブロック剤等の固形製剤、乳剤、ゲル剤、液剤等の液状製剤、発泡製剤、エアゾール製剤、フォーム製剤等とすることができる。
The bath agent of the present invention is a bath agent that exhibits alkalinity when dissolved in bath water. Specifically, the pH when the bathing agent of the present invention is dissolved in bath water is preferably 9-11. If the pH is less than 9, the bathing effect such as heat retention and recovery from fatigue may be insufficient, and it may not be possible to enjoy the feeling of bathing, smoothness and smoothness. If it exceeds, the skin irritation becomes stronger, which is not preferable for people with sensitive skin.
The bathing agent of the present invention is preferably completely dissolved within 20 minutes in a solubility test in which 1 g of bathing agent is dissolved in 1000 g of ion-exchanged water at 20 ° C. Thereby, when the bath agent of this invention is thrown into bath water, it can be dissolved rapidly.
In addition, the dosage form of the bath preparation of the present invention is not particularly limited, and for example, liquid preparations such as powders, granules, fine granules, tablets, blocking agents, and the like, emulsions, gels, liquids and the like. It can be set as a formulation, an effervescent formulation, an aerosol formulation, a foam formulation, etc.
本発明のスケール抑制方法は、炭酸塩を溶解させたアルカリ性を示す浴湯に発生するスケールを、リン酸三ナトリウムを添加することにより抑制する方法である。上述したとおりリン酸三ナトリウムは、炭酸塩を含有するアルカリ性の浴湯中でのスケールの抑制に高い効果を発揮する。
本発明のスケール抑制方法において、リン酸三ナトリウムの添加量は、浴湯中、通常1.5〜15ppm、好ましくは1.5〜7.5ppmとすることが好ましい。リン酸三ナトリウムの添加量が少ないと、スケールの抑制効果が不十分となるおそれがあり、一方、多すぎると上述したような使用感が不十分となるおそれがある。
The scale suppression method of the present invention is a method for suppressing the scale generated in alkaline bath water in which carbonate is dissolved by adding trisodium phosphate. As described above, trisodium phosphate exhibits a high effect in suppressing scale in an alkaline bath containing carbonate.
In the scale suppression method of the present invention, the amount of trisodium phosphate added is usually 1.5 to 15 ppm, preferably 1.5 to 7.5 ppm in the bath water. If the amount of trisodium phosphate added is small, the effect of suppressing the scale may be insufficient. On the other hand, if the amount is too large, the above-described feeling of use may be insufficient.
本発明のスケール抑制方法を適用する浴湯は、炭酸塩によりアルカリ性を呈するようにした浴湯であればよく、必要に応じて、炭酸塩の他に、上述した任意成分を溶解もしくは分散させたものであってもよい。炭酸塩としては、上述した本発明の入浴剤に配合されるものと同様のものを用いればよい。浴湯中の炭酸塩濃度は、特に制限されないが、通常40〜150ppmとするのが好ましく、この範囲において十分な抑制効果を得ることができる。浴湯が上述した任意成分を溶解もしくは分散させたものである場合、それらの量は、本発明の効果を損なわない範囲で適宜設定すればよい。
本発明のスケール抑制方法は、炭酸塩とともにリン酸三ナトリウムを予め配合してなる本発明の入浴剤を浴湯(さら湯)に投入することにより実施されてもよいし、少なくとも炭酸塩を含む公知の入浴剤を投入した浴湯に別途リン酸三ナトリウムを添加することにより実施されてもよい。
The bath water to which the scale suppression method of the present invention is applied may be a bath water that exhibits alkalinity with a carbonate, and if necessary, in addition to the carbonate, the above-mentioned optional components are dissolved or dispersed. It may be a thing. What is necessary is just to use the thing similar to what is mix | blended with the bathing agent of this invention mentioned above as carbonate. The carbonate concentration in the bath water is not particularly limited, but is usually preferably 40 to 150 ppm, and a sufficient suppressing effect can be obtained in this range. When the bath water is one in which the above-mentioned optional components are dissolved or dispersed, the amount thereof may be set as appropriate within a range not impairing the effects of the present invention.
The scale suppression method of the present invention may be carried out by adding the bathing agent of the present invention, which is prepared by premixing trisodium phosphate together with carbonate, into bath water (saray hot water), or at least including a carbonate. This may be carried out by separately adding trisodium phosphate to the bath water in which the bath agent is added.
以下に実施例において本発明を具体的に説明するが、これらの実施例に限定されるものではない。 EXAMPLES The present invention will be specifically described below with reference to examples, but the present invention is not limited to these examples.
(実施例1および比較例1、2)
プラスチック製の浴槽に、40℃の浴湯(赤穂市水道水(硬度45〜50mg/L)を使用)200Lを溜め、その中に表1に示す各処方で作製した粉末状入浴剤を30g投入し、よくかき混ぜながら溶解させ、浴槽側面に付着している気泡をスポンジで取り除いた後、12時間静置してから浴湯を排水する、という一連の操作を、途中に浴槽を洗浄することなく合計3回繰り返した。その後、浴槽を風乾させ、浴槽の側面を素手で触った時のざらつきの度合いを「ざらつきを感じる」、「ざらつきを感じない」の2段階の基準で評価した。なお、評価はパネラー10名(男性4名、女性6名)により行い、結果はそれぞれの基準に判定した人数が占める割合(%)で表した。結果を表1に示す。
なお、表1に示す処方Aの入浴剤を上述した条件(40℃の浴湯200Lに対して入浴剤30g)で浴湯に溶解させた時のpHは9.75であり、アルカリ性を示した。
(Example 1 and Comparative Examples 1 and 2)
In a plastic bathtub, 200 L of 40 ° C. bath water (using Ako city tap water (hardness 45 to 50 mg / L)) is stored, and 30 g of powdered bathing agent prepared according to each formulation shown in Table 1 is put therein. Without stirring the bathtub in the middle of the process, the mixture is dissolved while stirring well, the bubbles adhering to the side of the bathtub are removed with a sponge, and the bath is drained after standing for 12 hours. Repeated a total of 3 times. Then, the bathtub was air-dried, and the degree of roughness when the side of the bathtub was touched with bare hands was evaluated based on a two-step criterion of “feeling roughness” and “not feeling roughness”. The evaluation was performed by 10 panelists (4 men and 6 women), and the result was expressed as a percentage (%) of the number of persons determined according to each standard. The results are shown in Table 1.
The pH when the bathing agent of the formulation A shown in Table 1 was dissolved in bathing water under the above-described conditions (30 g bathing bath with respect to 200 L bathing bath at 40 ° C.) was 9.75, indicating alkalinity. .
表1から、スケールの発生を抑制するための成分を全く含有しない入浴剤(処方B)で感じられる浴槽のざらつきは、一般的な金属イオン封鎖剤であるクエン酸ナトリウムやエデト酸ナトリウムを含有させた入浴剤(処方D、E)では殆ど改善されず、また、ポリアクリル酸ナトリウムを含有させた処方Cの入浴剤でも改善はされるものの十分には抑制されない、ことが明らかである。これに対して、リン酸三ナトリウムを含有する本発明の入浴剤(処方A)では、浴槽のざらつきを確実に抑制できることが分かる。 From Table 1, the roughness of the bathtub felt with the bath additive (prescription B) that does not contain any component for suppressing the generation of scales includes sodium citrate and sodium edetate, which are general sequestering agents. It is clear that the bathing agents (prescriptions D and E) are hardly improved, and the bathing agent of the formulation C containing sodium polyacrylate is improved but not sufficiently suppressed. On the other hand, it turns out that the roughening of a bathtub can be suppressed reliably in the bath agent (prescription A) of the present invention containing trisodium phosphate.
(実施例2および比較例5)
実施例2においては表1に示す処方Aで作製した入浴剤を、比較例5においては表1に示す処方Bで作製した入浴剤を用い、実施例1と同様、プラスチック製の浴槽に40℃の浴湯(赤穂市水道水(硬度45〜50mg/L)を使用)200Lを溜め、各々30g投入しよくかき混ぜながら溶解させ、浴槽側面に付着している気泡をスポンジで取り除いた後、12時間静置してから浴湯を排水し、浴槽を風乾させた(ここでは、一連の操作は1回のみ行った)。その後、喫水線より下の浴槽側面を擦り取って白色粉末を採取し、この採取物を顕微鏡(OLYMPUS社製「B071」)にて倍率400倍で観察した。実施例2における結果(顕微鏡写真)を図1に、比較例5における結果(顕微鏡写真)を図2に、それぞれ示す。また、比較例5で採取した白色粉末については、医薬部外品原料規格(2006)(以下、「外原規」とも言う)に記載されている、カルシウム塩および炭酸塩の定性反応試験法にしたがい分析し、炭酸カルシウムを主成分とするものであることを確認した。
図1および図2に示す通り、リン酸三ナトリウムを含有しない入浴剤を使用した比較例5では、粒状の塊(スケール)が多数確認されるのに対して、リン酸三ナトリウムを含有する本発明の入浴剤を使用した実施例2では、所々に小さい点が認められる程度であった。つまり、比較例5は、実施例2よりもスケール(炭酸カルシウム)の結晶が大きく成長している。このことから、リン酸三ナトリウムを含有させることによって、スケールの結晶成長を抑制できることが明らかである。
(Example 2 and Comparative Example 5)
In Example 2, the bathing agent prepared according to the formulation A shown in Table 1 was used, and in Comparative Example 5, the bathing agent prepared according to the formulation B shown in Table 1 was used. Of bath water (using Ako City tap water (hardness: 45-50 mg / L)), 30 g of each was added, dissolved while stirring well, and the bubbles adhering to the sides of the bathtub were removed with a sponge, 12 hours After standing still, the hot water was drained, and the bathtub was air-dried (here, a series of operations was performed only once). Thereafter, the side surface of the bathtub below the water line was scraped off to collect white powder, and this sample was observed with a microscope (“B071” manufactured by OLYMPUS) at a magnification of 400 times. The result (micrograph) in Example 2 is shown in FIG. 1, and the result (micrograph) in Comparative Example 5 is shown in FIG. In addition, the white powder collected in Comparative Example 5 conforms to the qualitative reaction test method for calcium salts and carbonates described in the Quasi-drug Raw Material Standard (2006) (hereinafter also referred to as “External Code”). Accordingly, analysis was conducted and it was confirmed that the main component was calcium carbonate.
As shown in FIG. 1 and FIG. 2, in Comparative Example 5 using a bath agent that does not contain trisodium phosphate, a large number of granular lumps (scales) are confirmed, whereas a book containing trisodium phosphate. In Example 2 using the bathing agent of the invention, small points were observed in some places. That is, in Comparative Example 5, crystals of scale (calcium carbonate) grow larger than Example 2. From this, it is clear that the crystal growth of scale can be suppressed by containing trisodium phosphate.
(参考例1)
本発明の入浴剤において必須成分とするリン酸三ナトリウムと、同じリン酸ナトリウム塩である、リン酸二水素ナトリウムおよびリン酸水素二ナトリウムとについて、入浴剤に配合する成分としての適性(すなわち、溶解性およびpH)を下記の方法で調べた。結果を表2に示す。
<溶解性>
各リン酸ナトリウム塩(いずれも、太平化学産業(株)製の外原規グレードを使用)1gを20℃に保持したイオン交換水100mL中に投入して静置し、10分毎に目視にて観察することにより、各リン酸ナトリウム塩の溶け残りの有無を確認した。
<pH>
各リン酸ナトリウム塩(いずれも、太平化学産業(株)製の外原規グレードを使用)1gを20℃に保持したイオン交換水100mLに投入し、マグネチックスターラーで攪拌しながら完全に溶解させ、得られた溶液のpHを測定した。
(Reference Example 1)
The trisodium phosphate as an essential component in the bath agent of the present invention and the same sodium phosphate salt, sodium dihydrogen phosphate and disodium hydrogen phosphate, are suitable as components to be blended in the bath agent (that is, Solubility and pH) were examined by the following methods. The results are shown in Table 2.
<Solubility>
1 g of each sodium phosphate salt (both using outer standard grades manufactured by Taihei Chemical Industry Co., Ltd.) is poured into 100 mL of ion-exchanged water maintained at 20 ° C. and left to stand visually every 10 minutes. The presence or absence of undissolved residues of each sodium phosphate was confirmed.
<PH>
1 g of each sodium phosphate salt (both using Taihei Chemical Sangyo Co., Ltd.'s outer original standard grade) is added to 100 mL of ion-exchanged water maintained at 20 ° C. and completely dissolved while stirring with a magnetic stirrer. The pH of the obtained solution was measured.
表2から、リン酸二水素ナトリウムは、水に溶解させたときに酸性を示すものであり、pHの低下をまねくことから、アルカリ性入浴剤による湯ざわりや感触を損なうことがあり、しかも皮膚や粘膜に刺激を及ぼすことが懸念されるので、浴湯に溶解させる入浴剤に配合する成分としては適さないと考えられる。また、リン酸水素二ナトリウムは、溶解性が他のリン酸ナトリウム塩よりも低く、浴湯に添加したときに溶け残りが懸念されるので、浴湯に溶解させる入浴剤に配合する成分としては適さないと考えられる。これに対して、リン酸三ナトリウムは、浴湯に適したアルカリ性を示すとともに、浴湯に添加した時にも速やかに溶解しうるものであり、入浴剤に配合する成分として最適であることが明らかである。 From Table 2, sodium dihydrogen phosphate exhibits acidity when dissolved in water, and lowers the pH, which may impair the texture and feel of the alkaline bathing agent. Since it is feared that the mucous membrane is irritated, it is considered that it is not suitable as a component to be blended in a bath agent dissolved in bath water. In addition, disodium hydrogen phosphate is lower in solubility than other sodium phosphate salts, and there is concern about undissolved residue when added to bath water. It is considered unsuitable. On the other hand, trisodium phosphate exhibits alkalinity suitable for bath water, and can be dissolved quickly when added to bath water. It is.
(参考例2)
浴湯をアルカリ性にするためのアルカリ成分として本発明の入浴剤の必須成分である炭酸塩(炭酸ナトリウム)を用いた場合と、重炭酸塩(炭酸水素ナトリウム)を用いた場合とについて、スケールの発生し易さの違いを下記の方法で調べた。
すなわち、プラスチック製の浴槽に、40℃の浴湯(赤穂市水道水(硬度45〜50mg/L)を使用)200Lを溜め、その中に、a)炭酸ナトリウム12.9gおよび硫酸ナトリウム16.5g、または、b)炭酸水素ナトリウム12.9gおよび硫酸ナトリウム16.5g、を投入し、よくかき混ぜながら溶解させ、浴槽側面に付着している気泡をスポンジで取り除いた後、3日間静置してから浴湯を排水した。その後、浴槽を風乾させ、パネラー10名(男性4名、女性6名)により浴槽の側面を素手で触った時のざらつきの度合いを、実施例1と同様に、「ざらつきを感じる」、「ざらつきを感じない」の2段階の基準で評価した。
その結果、a)の場合(すなわち、炭酸塩を用いた場合)、90%のパネラーが「ざらつきを感じる」とし、「ざらつきを感じない」と判定したパネラーは僅か10%であったのに対し、b)の場合(すなわち、重炭酸塩を用いた場合)、100%のパネラーが「ざらつきを感じない」と判定した。
このことから、炭酸塩(炭酸ナトリウム)を含有する場合にはスケールが発生しやすいが、重炭酸塩(炭酸水素ナトリウム)を用いた場合にはスケールは殆ど発生しないことが分かる。つまり、アルカリ性の浴湯においてスケールが発生し浴槽にざらつきが生じるという問題は、炭酸塩を含有することによって特異的に発生する問題であると言える。
(Reference Example 2)
When using carbonate (sodium carbonate), which is an essential component of the bathing agent of the present invention, as an alkaline component for making bath water alkaline, and when using bicarbonate (sodium bicarbonate) The difference in ease of occurrence was examined by the following method.
That is, 200 L of 40 ° C. bath water (using Ako City tap water (hardness: 45 to 50 mg / L)) was stored in a plastic bathtub, and a) 12.9 g of sodium carbonate and 16.5 g of sodium sulfate. Or b) 12.9 g of sodium hydrogen carbonate and 16.5 g of sodium sulfate are added, dissolved while stirring well, air bubbles adhering to the side of the bathtub are removed with a sponge, and then left to stand for 3 days. The bath water was drained. Then, the bathtub was air-dried, and the degree of roughness when touching the side of the bathtub with bare hands by 10 panelists (4 men and 6 women) was the same as in Example 1. The evaluation was based on a two-step criterion of “I don't feel“.
As a result, in the case of a) (that is, when carbonate is used), 90% of the panelists answered “feel rough” and only 10% of the panelists judged “not rough”. B) (ie, when bicarbonate was used), 100% of the panelists determined that “no roughness”.
From this, it can be seen that scale is likely to occur when carbonate (sodium carbonate) is contained, but scarcely occurs when bicarbonate (sodium bicarbonate) is used. That is, it can be said that the problem that the scale is generated in the alkaline bath water and the bathtub is rough is a problem that occurs specifically by containing carbonate.
以下にさらに本発明の入浴剤の処方例を示すが、本発明はこれらの処方例に限定されるものではない。 Although the example of the bath preparation of this invention is further shown below, this invention is not limited to these examples of preparation.
(処方例1)
炭酸ナトリウム : 40.0質量%
炭酸水素ナトリウム : 50.0質量%
無水ケイ酸 : 8.0質量%
香料(ハーブ調の香り): 1.0質量%
リン酸三ナトリウム : 1.0質量%
合計 :100.0質量%
この処方例1の粉末状入浴剤30gを40℃のお湯200Lに投入したときのpHは、9.3であった。
(Prescription Example 1)
Sodium carbonate: 40.0% by mass
Sodium bicarbonate: 50.0% by mass
Silicic anhydride: 8.0% by mass
Fragrance (herb-like fragrance): 1.0% by mass
Trisodium phosphate: 1.0% by mass
Total: 100.0% by mass
When 30 g of the powdered bath of Formulation Example 1 was added to 200 L of hot water at 40 ° C., the pH was 9.3.
(処方例2)
炭酸ナトリウム : 40.0質量%
炭酸水素ナトリウム : 50.0質量%
無水ケイ酸 : 6.0質量%
香料(ハーブ調の香り): 1.0質量%
リン酸三ナトリウム : 3.0質量%
合計 :100.0質量%
この処方例2の粉末状入浴剤30gを40℃のお湯200Lに投入したときのpHは、9.3であった。
(Prescription example 2)
Sodium carbonate: 40.0% by mass
Sodium bicarbonate: 50.0% by mass
Silicic anhydride: 6.0% by mass
Fragrance (herb-like fragrance): 1.0% by mass
Trisodium phosphate: 3.0% by mass
Total: 100.0% by mass
When 30 g of the powdered bath of Formulation Example 2 was added to 200 L of hot water at 40 ° C., the pH was 9.3.
(処方例3)
炭酸ナトリウム : 40.0質量%
硫酸ナトリウム : 50.0質量%
無水ケイ酸 : 4.0質量%
香料(ユズ調の香り) : 1.0質量%
リン酸三ナトリウム : 5.0質量%
合計 :100.0質量%
この処方例3の粉末状入浴剤30gを40℃のお湯200Lに投入したときのpHは、9.5であった。
(Prescription Example 3)
Sodium carbonate: 40.0% by mass
Sodium sulfate: 50.0% by mass
Silicic anhydride: 4.0% by mass
Fragrance (Yuzu-like fragrance): 1.0% by mass
Trisodium phosphate: 5.0% by mass
Total: 100.0% by mass
The pH when 30 g of the powdered bath of Formulation Example 3 was added to 200 L of hot water at 40 ° C. was 9.5.
(処方例4)
炭酸ナトリウム : 40.0質量%
硫酸ナトリウム : 50.0質量%
無水ケイ酸 : 2.0質量%
香料(森の香り) : 1.0質量%
リン酸三ナトリウム : 7.0質量%
合計 :100.0質量%
この処方例4の粉末状入浴剤30gを40℃のお湯200Lに投入したときのpHは、9.5であった。
(Prescription Example 4)
Sodium carbonate: 40.0% by mass
Sodium sulfate: 50.0% by mass
Silicic anhydride: 2.0% by mass
Fragrance (forest fragrance): 1.0% by mass
Trisodium phosphate: 7.0% by mass
Total: 100.0% by mass
The pH when 30 g of the powdered bath of Formulation Example 4 was added to 200 L of hot water at 40 ° C. was 9.5.
(処方例5)
炭酸ナトリウム : 60.0質量%
炭酸水素ナトリウム : 30.0質量%
無水ケイ酸 : 6.0質量%
香料(ハーブ調の香り): 1.0質量%
リン酸三ナトリウム : 3.0質量%
合計 :100.0質量%
この処方例5の粉末状入浴剤30gを40℃のお湯200Lに投入したときのpHは、9.7であった。
(Prescription Example 5)
Sodium carbonate: 60.0% by mass
Sodium bicarbonate: 30.0% by mass
Silicic anhydride: 6.0% by mass
Fragrance (herb-like fragrance): 1.0% by mass
Trisodium phosphate: 3.0% by mass
Total: 100.0% by mass
When 30 g of the powdered bath of Formulation Example 5 was added to 200 L of hot water at 40 ° C., the pH was 9.7.
(処方例6)
炭酸ナトリウム : 60.0質量%
硫酸ナトリウム : 30.0質量%
無水ケイ酸 : 4.0質量%
香料(ユズ調の香り) : 1.0質量%
リン酸三ナトリウム : 5.0質量%
合計 :100.0質量%
この処方例6の粉末状入浴剤30gを40℃のお湯200Lに投入したときのpHは、9.8であった。
(Prescription Example 6)
Sodium carbonate: 60.0% by mass
Sodium sulfate: 30.0% by mass
Silicic anhydride: 4.0% by mass
Fragrance (Yuzu-like fragrance): 1.0% by mass
Trisodium phosphate: 5.0% by mass
Total: 100.0% by mass
When 30 g of the powdered bath agent of this formulation example 6 was added to 200 L of hot water at 40 ° C., the pH was 9.8.
(処方例7)
炭酸ナトリウム : 60.0質量%
硫酸ナトリウム : 30.0質量%
無水ケイ酸 : 2.0質量%
香料(森の香り) : 1.0質量%
リン酸三ナトリウム : 7.0質量%
合計 :100.0質量%
この処方例7の粉末状入浴剤30gを40℃のお湯200Lに投入したときのpHは、9.9であった。
(Prescription Example 7)
Sodium carbonate: 60.0% by mass
Sodium sulfate: 30.0% by mass
Silicic anhydride: 2.0% by mass
Fragrance (forest fragrance): 1.0% by mass
Trisodium phosphate: 7.0% by mass
Total: 100.0% by mass
When 30 g of the powdered bath of Formulation Example 7 was added to 200 L of hot water at 40 ° C., the pH was 9.9.
(処方例8)
炭酸ナトリウム : 90.0質量%
無水ケイ酸 : 6.0質量%
香料(ハーブ調の香り): 1.0質量%
リン酸三ナトリウム : 3.0質量%
合計 :100.0質量%
この処方例8の粉末状入浴剤30gを40℃のお湯200Lに投入したときのpHは、10.1であった。
(Prescription Example 8)
Sodium carbonate: 90.0% by mass
Silicic anhydride: 6.0% by mass
Fragrance (herb-like fragrance): 1.0% by mass
Trisodium phosphate: 3.0% by mass
Total: 100.0% by mass
The pH when 30 g of the powdered bath of Formulation Example 8 was added to 200 L of hot water at 40 ° C. was 10.1.
(処方例9)
炭酸ナトリウム : 90.0質量%
無水ケイ酸 : 4.0質量%
香料(ユズ調の香り) : 1.0質量%
リン酸三ナトリウム : 5.0質量%
合計 :100.0質量%
この処方例9の粉末状入浴剤30gを40℃のお湯200Lに投入したときのpHは、10.1であった。
(Prescription Example 9)
Sodium carbonate: 90.0% by mass
Silicic anhydride: 4.0% by mass
Fragrance (Yuzu-like fragrance): 1.0% by mass
Trisodium phosphate: 5.0% by mass
Total: 100.0% by mass
The pH when 30 g of the powdered bath of Formulation Example 9 was added to 200 L of hot water at 40 ° C. was 10.1.
(処方例10)
炭酸ナトリウム : 90.0質量%
無水ケイ酸 : 2.0質量%
香料(森の香り) : 1.0質量%
リン酸三ナトリウム : 7.0質量%
合計 :100.0質量%
この処方例10の粉末状入浴剤30gを40℃のお湯200Lに投入したときのpHは、10.1であった。
(Prescription Example 10)
Sodium carbonate: 90.0% by mass
Silicic anhydride: 2.0% by mass
Fragrance (forest fragrance): 1.0% by mass
Trisodium phosphate: 7.0% by mass
Total: 100.0% by mass
When 30 g of the powdered bath agent of the formulation example 10 was added to 200 L of hot water at 40 ° C., the pH was 10.1.
(処方例11)
炭酸ナトリウム : 88.0質量%
無水ケイ酸 : 1.0質量%
香料(森の香り) : 1.0質量%
リン酸三ナトリウム : 10.0質量%
合計 :100.0質量%
この処方例11の粉末状入浴剤30gを40℃のお湯200Lに投入したときのpHは、10.0であった。
(Prescription Example 11)
Sodium carbonate: 88.0% by mass
Silicic anhydride: 1.0% by mass
Fragrance (forest fragrance): 1.0% by mass
Trisodium phosphate: 10.0% by mass
Total: 100.0% by mass
The pH when 10.0 g of the powdered bath of Formulation Example 11 was added to 200 L of hot water at 40 ° C. was 10.0.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009127911A JP5513775B2 (en) | 2009-05-27 | 2009-05-27 | Bath salt and scale control method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009127911A JP5513775B2 (en) | 2009-05-27 | 2009-05-27 | Bath salt and scale control method |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2010275212A JP2010275212A (en) | 2010-12-09 |
JP5513775B2 true JP5513775B2 (en) | 2014-06-04 |
Family
ID=43422520
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009127911A Active JP5513775B2 (en) | 2009-05-27 | 2009-05-27 | Bath salt and scale control method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5513775B2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5945431B2 (en) * | 2012-03-02 | 2016-07-05 | 五洲薬品株式会社 | Bath preparation |
JP6340677B2 (en) * | 2012-08-07 | 2018-06-13 | 学校法人神奈川大学 | Bath additive |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01175928A (en) * | 1987-12-28 | 1989-07-12 | Lion Corp | Bathing agent |
JPH04326996A (en) * | 1991-04-24 | 1992-11-16 | Toda Constr Co Ltd | Method and apparatus for preventing adhesion of lime component using spring water |
IN185580B (en) * | 1991-08-30 | 2001-03-03 | Albright & Wilson Uk Ltd | |
JP2002154951A (en) * | 2000-09-08 | 2002-05-28 | Hayashibara Bijutsu Minto:Kk | Brain wave inhibitor |
JP2002212057A (en) * | 2001-01-17 | 2002-07-31 | Tsumura & Co | Bathing agent composition |
JP2006248995A (en) * | 2005-03-10 | 2006-09-21 | Earth Chem Corp Ltd | Powdery bathing agent |
CA2612615C (en) * | 2005-06-21 | 2014-11-25 | V. Mane Fils | Gellan seamless breakable capsule and process for manufacturing thereof |
JP2009096735A (en) * | 2007-10-15 | 2009-05-07 | Koyo Kasei Kk | Manufacturing method of alkaline additive for bath having hot bath effect and spa-like quality |
-
2009
- 2009-05-27 JP JP2009127911A patent/JP5513775B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2010275212A (en) | 2010-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6203539B2 (en) | Skin cleanser composition | |
KR101489701B1 (en) | Redispersible powder-dispersed cosmetic | |
JP2011148722A (en) | Nonaqueous, warming cleanser composition for skin | |
JP5513775B2 (en) | Bath salt and scale control method | |
JP6453665B2 (en) | Cleaning composition | |
JP2012250970A (en) | Cosmetic solution, method for producing the cosmetic solution, and cosmetic method | |
JP4504729B2 (en) | Two-component bath agent | |
JP4806601B2 (en) | Liquid bath agent | |
JP4814745B2 (en) | Liquid bath agent | |
JPH08325137A (en) | Bathing agent | |
JP2011184361A (en) | Solid bathing agent composition | |
JP2008308464A (en) | Bilayer type nail treatment cosmetic | |
JP2005097238A (en) | Bathing agent composition | |
JP2013139411A (en) | Transparent double-layer cleansing cosmetic | |
JP2021187784A (en) | Granule-blended foamable tablet | |
JP4157007B2 (en) | Bath additive | |
JP2005281151A (en) | Bathing agent and method for producing the same | |
JP2973368B2 (en) | Bath composition | |
KR102253878B1 (en) | Manufacturing method for liquid soap | |
JP2006188435A (en) | Skin-cleansing agent composition | |
JPH07309741A (en) | Bathing agent composition | |
JP2008056794A (en) | Detergent composition | |
JP2009096735A (en) | Manufacturing method of alkaline additive for bath having hot bath effect and spa-like quality | |
JP2005023089A (en) | Bathing agent | |
JP4348208B2 (en) | Compression mold bath agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120227 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20130528 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130611 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130809 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140304 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140328 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5513775 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |